Serum Matrix Metalloproteinases as Quantitative Biomarkers for Myocardial Fibrosis and Sudden Cardiac Death Risk Stratification in Patients With Hypertrophic Cardiomyopathy.
about
Current Understanding of the Pathophysiology of Myocardial Fibrosis and Its Quantitative Assessment in Heart Failure.Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Promotes Hepatic Stellate Cells Migration via Canonical NF-κB/MMP9 Pathway.Properties and Immune Function of Cardiac Fibroblasts.Biomarkers of Myocardial Fibrosis: Revealing the Natural History of Fibrogenesis in Fabry Disease Cardiomyopathy.
P2860
Serum Matrix Metalloproteinases as Quantitative Biomarkers for Myocardial Fibrosis and Sudden Cardiac Death Risk Stratification in Patients With Hypertrophic Cardiomyopathy.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Serum Matrix Metalloproteinase ...... h Hypertrophic Cardiomyopathy.
@ast
Serum Matrix Metalloproteinase ...... h Hypertrophic Cardiomyopathy.
@en
type
label
Serum Matrix Metalloproteinase ...... h Hypertrophic Cardiomyopathy.
@ast
Serum Matrix Metalloproteinase ...... h Hypertrophic Cardiomyopathy.
@en
prefLabel
Serum Matrix Metalloproteinase ...... h Hypertrophic Cardiomyopathy.
@ast
Serum Matrix Metalloproteinase ...... h Hypertrophic Cardiomyopathy.
@en
P2093
P1476
Serum Matrix Metalloproteinase ...... h Hypertrophic Cardiomyopathy.
@en
P2093
Anna Suling
Dennis Säring
Elisabeth Krämer
Giulia Mearini
Gunnar Lund
Julia Münch
Lucie Carrier
Maxim Avanesov
Monica Patten
Peter Bannas
P304
P356
10.1016/J.CARDFAIL.2016.03.010
P577
2016-03-24T00:00:00Z